| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/27/2010 | EP2146720A1 Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 01/27/2010 | EP2146719A1 Process for making galantamine |
| 01/27/2010 | EP2146718A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 01/27/2010 | EP2146717A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 01/27/2010 | EP2146716A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 01/27/2010 | EP2146715A1 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups |
| 01/27/2010 | EP2146714A1 Use of 4-cyclopropylmethoxy-<i>n</i>-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease |
| 01/27/2010 | EP2146713A2 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas |
| 01/27/2010 | EP2146712A1 Aryl heterocyclic cgrp receptor antagonists |
| 01/27/2010 | EP2146711A1 Ischemia/reperfusion protection compositions and methods of using |
| 01/27/2010 | EP2146710A1 P38alpha as a therapeutic target in bladder carcinoma |
| 01/27/2010 | EP2146709A2 Iminosugar for treatment of tumors |
| 01/27/2010 | EP2146708A1 Composition having lipolytic activity, production method thereof and use of the composition. |
| 01/27/2010 | EP2146703A1 Src family kinase inhibitors |
| 01/27/2010 | EP2146701A1 Biodegradable polyanhydrides with natural bioactive molecules |
| 01/27/2010 | EP2146699A2 Pharmaceutical compositions comprising oxcarbazepine |
| 01/27/2010 | EP2146698A2 Rapidly dispersible vaginal tablet that provides a bioadhesive gel |
| 01/27/2010 | EP2146697A1 Pharmaceutical compositions |
| 01/27/2010 | EP2146695A2 Pharmaceutical compositions |
| 01/27/2010 | EP2146693A2 Solifenacin compositions |
| 01/27/2010 | EP2146692A1 Proliposomal and liposomal compositions |
| 01/27/2010 | EP2146690A2 Oral cephalotaxine dosage forms |
| 01/27/2010 | EP2146577A1 Ziprasidone formulations |
| 01/27/2010 | EP2146576A1 Treatment of down syndrome with benzodiazepine receptor antagonists |
| 01/27/2010 | EP2146573A1 Unit dose formulations and methods of treating and preventing thrombosis with thromboxane receptor antagonists |
| 01/27/2010 | EP2146572A1 Bicyclic anilide heterocyclic cgrp receptor antagonists |
| 01/27/2010 | EP2069020B1 Benzo[d]isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine |
| 01/27/2010 | EP1830833B1 Combination of a glycine transporter (glyt1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia as well as its preparation and use thereof |
| 01/27/2010 | EP1781119B1 Lipoic acid concentrate |
| 01/27/2010 | EP1732574B1 Use of o-atp for the treatment of diseases involving angiogenesis |
| 01/27/2010 | EP1711461B1 N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them |
| 01/27/2010 | EP1656353B1 Gabanergic modulators |
| 01/27/2010 | EP1562612B1 Combination product of inhibitor of the src family of non-receptor tyrosine kinases and gemcitabine for use in the treatment or prophlaxix of pancreatic cancer |
| 01/27/2010 | EP1554286B1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| 01/27/2010 | EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 01/27/2010 | EP1343485B1 Drug delivery system comprising a lipid-based nitric oxide donor |
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/27/2010 | EP1191937B1 Adhesive n,o-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins |
| 01/27/2010 | CN101636169A Self-assembling amphiphilic polymers as antiviral agents |
| 01/27/2010 | CN101636168A SP35 antibodies and uses thereof |
| 01/27/2010 | CN101636167A Agent for facilitating the development of brain in infant comprising milk-derived phospholipid and food composition comprising the same |
| 01/27/2010 | CN101636166A Progesterone for the prevention of spontaneous preterm birth |
| 01/27/2010 | CN101636165A Treatment for dry eye using testosterone and progestagen |
| 01/27/2010 | CN101636164A Treatment for dry eye |
| 01/27/2010 | CN101636163A Pirenoxine-containing suspension-type aqueous preparation |
| 01/27/2010 | CN101636162A Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms |
| 01/27/2010 | CN101636161A 1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to |
| 01/27/2010 | CN101636160A 7,8-saturated-4,5-epoxy-morphinanium analogs |
| 01/27/2010 | CN101636159A Pharmaceutical product for prevention and treatment of alzheimer's dementia |
| 01/27/2010 | CN101636158A Reduction of adverse events.after percutaneous intervention by use of a thrombin receptor antagonist |
| 01/27/2010 | CN101636157A Adenylyl cyclases as novel targets for antibacterial interventions |
| 01/27/2010 | CN101636156A Pharmaceutical alkyl gallate composition. |
| 01/27/2010 | CN101636155A Inhibitors of diacylglycerol O-acylotransferase type 1 enzyme |
| 01/27/2010 | CN101636154A Inhibitors of the TASK-1 and TASK-3 ion channel |
| 01/27/2010 | CN101633650A Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 01/27/2010 | CN101633646A Salts of valsartan |
| 01/27/2010 | CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101633636A Peptidomimetic protease inhibitors |
| 01/27/2010 | CN101632686A Use of glycosaminoglycan for restoring glycocalyx |
| 01/27/2010 | CN101632685A Application of aldehyde-modified polysaccharide containing carboxyl to preparing medicine and medical material |
| 01/27/2010 | CN101632684A Application of gynostemma pentaphylla polysaccharide in preparing medicine or health-care product preventing and treating senile dementia |
| 01/27/2010 | CN101632683A Teniposide medicinal composition and preparation method thereof |
| 01/27/2010 | CN101632682A Orally taken product containing xylobiose and application thereof |
| 01/27/2010 | CN101632681A Glycerol fructose liposome drug combination injection and preparation method thereof |
| 01/27/2010 | CN101632680A Compound alendronate sodium vitamin D3 enteric-coated tablet and preparation method thereof |
| 01/27/2010 | CN101632679A Composite vitamin for injection and preparation method thereof |
| 01/27/2010 | CN101632678A Losartan potassium hydrochlorothiazide composition and preparation method thereof |
| 01/27/2010 | CN101632677A Suspension powder injection of cefoperazone sodium and tazobactam sodium pharmaceutical composition and new application thereof |
| 01/27/2010 | CN101632676A Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
| 01/27/2010 | CN101632675A Ferrous fumarate and folic acid pharmaceutical composition and liposome solid preparation thereof |
| 01/27/2010 | CN101632674A Application of imatinib mesylate in preparing medicament for treating hepatitis B |
| 01/27/2010 | CN101632673A Medicinal composition containing losartan, pioglitazone and rosuvastatin and new application thereof |
| 01/27/2010 | CN101632672A Compound medicinal composition for treating hypertension |
| 01/27/2010 | CN101632671A Suspensoid powder injection of piperacillin sodium sulbactam sodium medicine composition and novel application thereof |
| 01/27/2010 | CN101632670A Suspension powder injection of piperacillin sodium and tazobactam sodium pharmaceutical composition and new application thereof |
| 01/27/2010 | CN101632669A Method of using diketopiperazines and composition containing them |
| 01/27/2010 | CN101632668A Oral pharmaceutical composition |
| 01/27/2010 | CN101632667A New application of injection omeprazole sodium for treating gastric mucosa-associated lymphoid tissue lymphoma |
| 01/27/2010 | CN101632666A Drug composition used for treating high blood pressure |
| 01/27/2010 | CN101632665A Novel torasemide oral medicine composition |
| 01/27/2010 | CN101632664A Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of HIV and inflammation |
| 01/27/2010 | CN101632663A Novel molecular target for neurotoxicity |
| 01/27/2010 | CN101632662A Sirolimus preparation and preparation process thereof |
| 01/27/2010 | CN101632661A Compound amoxicillin slow release dry suspension composition and preparation method thereof |
| 01/27/2010 | CN101632660A Suspensoid powder injection of amoxicillin sodium sulbactam sodium medicine composition and novel application thereof |
| 01/27/2010 | CN101632659A Medicinal composition of antiviral medicament and pidotimod, preparation method thereof and medicinal application thereof |
| 01/27/2010 | CN101632658A Medicinal preparation for treating colpitis and method for preparing same |
| 01/27/2010 | CN101632657A Application of artesunate as drug for treating systemic lupus erythematosus |
| 01/27/2010 | CN101632656A Preparation method of water-soluble irisolidone |
| 01/27/2010 | CN101632655A Resveratrol and bioflavonoid nutritional composition for delaying senility |
| 01/27/2010 | CN101632654A BAPTA and application of derivant thereof in rescuing and treatment medicine of hepatic failure |
| 01/27/2010 | CN101632653A BAPTA and application of derivant thereof in preparing analgesic drugs |
| 01/27/2010 | CN101632652A Combination drug for treating cervical cancer |
| 01/27/2010 | CN101632642A Formulations for oral administration of active compounds |
| 01/27/2010 | CN100584954C Method for producing paeonin metabolite-I by short lactobacillin fermentation |
| 01/27/2010 | CN100584945C Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 01/27/2010 | CN100584856C Hedera helix saponin, preparation method and antineoplastic use thereof |
| 01/27/2010 | CN100584854C Efficient parts of hydrangea paniculata, their preparing method and compositions and use thereof |
| 01/27/2010 | CN100584851C Phosphates of secondary alcohols |